IBOV 175,135.41 ▲ 0.31% IPSA 11,470.79 ▲ 0.89% IPC MEX 66,090.98 ▼ 0.15% MERVAL 3,001,209 ▼ 0.79% COLCAP 2,489.80 ▼ 0.59% BVL PERÚ 60,629.82 ▲ 0.25% USD/BRL5.16▲ 0.23% USD/MXN16.97▲ 0.06% USD/CLP926.00▲ 0.47% USD/COP3,150▲ 1.82% USD/PEN3.35▲ 0.16% USD/ARS1,512▼ 0.15% USD/UYU40.25▲ 1.53% USD/PYG5,905▲ 0.48% USD/BOB11.65▲ 2.81% USD/DOP58.25▲ 0.75% USD/CRC448.38▲ 1.62% USD/GTQ7.63▲ 2.37% USD/HNL26.83▲ 1.77% USD/NIO36.62▲ 0.79% USD/VES789.69▼ 0.08% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.73▲ 1.14% EUR/BRL6.01▲ 0.17% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 175,135.41 ▲ 0.31% IPSA 11,470.79 ▲ 0.89% IPC MEX 66,090.98 ▼ 0.15% MERVAL 3,001,209 ▼ 0.79% COLCAP 2,489.80 ▼ 0.59% BVL PERÚ 60,629.82 ▲ 0.25% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Friday, August 28, 2026

Brazilian Spider Venom: A New Hope in Cancer Fight

By · February 28, 2024 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

Scientists in Brazil discovered a spider on São Paulo’s coast with venom that fights cancer, offering a fresh approach to cancer treatment.

Twenty years ago, the Albert Einstein Israelita Hospital and Butantan Institute teams started this work.

They studied the Vitalius wacketi spider’s venom. Their goal was to find and refine molecules that could attack tumors.

These Brazilian teams have even secured patents for their methods. The venom showed promise against leukemia early on.

This is important because leukemia targets certain blood cells. The venom offers a better option than chemotherapy.

Thomas Rocha, a biochemist, shared insights with Xinhua. He and his team found a special toxin in the venom. This toxin, a big, unstable polyamine, sparked their interest.

Brazilian Spider Venom: A New Hope in Cancer Fight. (Photo Internet reproduction)
Brazilian Spider Venom: A New Hope in Cancer Fight. (Photo Internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

Later, a university student wanted to study the venom’s power to kill cancer cells. Rocha’s team tested it. They found one toxin in the Vitalius wacketi venom that stood out.

Rocha succeeded in making a synthetic version of this toxin. This means they don’t have to get it from spiders anymore.

Making this molecule in a lab is cheaper and simpler. Rocha explains that it also stays stable in the body and is easy to remove through the kidneys.

This research is still in the early stages. Scientists need to do more tests on cells and animals. They want to be sure it’s safe and works well before trying it on people.

If these steps go well, the next phase is clinical trials. This means testing it on humans to see if it can really fight cancer. Success here could lead to official approval for use in medicine.

This discovery is vital. It could change how we treat cancer, offering a new, effective option.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.